About
Technology
Issues
FAQ
Links
Official Page
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.